INTEGRATED BIOPHARMA INC (INBP) Gross profit 2016–2025
INTEGRATED BIOPHARMA INC (INBP) annual gross profit history from SEC filings — each fiscal year as reported.
$5.6MFY2025 · since FY2016: $5.5M → $5.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.6M | +43.2% |
| FY2024 | $3.9M | -4.4% |
| FY2023 | $4.1M | -38.0% |
| FY2022 | $6.6M | -30.9% |
| FY2021 | $9.5M | +40.9% |
| FY2020 | $6.7M | +8.1% |
| FY2019 | $6.2M | +24.7% |
| FY2018 | $5.0M | -25.2% |
| FY2017 | $6.7M | +21.1% |
| FY2016 | $5.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice